Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 12, Pages 2870-2879
Publisher
Oxford University Press (OUP)
Online
2013-06-27
DOI
10.1093/carcin/bgt231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
- (2011) Amber Yasmeen et al. GYNECOLOGIC ONCOLOGY
- Progesterone Receptor Inhibits Proliferation of Human Breast Cancer Cells via Induction of MAPK Phosphatase 1 (MKP-1/DUSP1)
- (2011) Chien-Cheng Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells
- (2011) Y. Zhuang et al. MOLECULAR CANCER RESEARCH
- Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer
- (2011) K Kim et al. ONCOGENE
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemoprevention Meets Glucose Control
- (2010) J. A. Engelman et al. Cancer Prevention Research
- Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
- (2010) M. Pollak Cancer Prevention Research
- Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth
- (2010) Indira Jutooru et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
- (2010) Indira Jutooru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells
- (2010) Bee K. Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- GT-094, a NO-NSAID, Inhibits Colon Cancer Cell Growth by Activation of a Reactive Oxygen Species-MicroRNA-27a: ZBTB10-Specificity Protein Pathway
- (2010) S. S. Pathi et al. MOLECULAR CANCER RESEARCH
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a
- (2010) I. Jutooru et al. MOLECULAR PHARMACOLOGY
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells
- (2009) Hsun-Jin Jan et al. CANCER LETTERS
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
- (2009) K. Kisfalvi et al. CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
- Sp1 coordinately regulatesde novolipogenesis and proliferation in cancer cells
- (2009) Suying Lu et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Thiazolidinediones Mimic Glucose Starvation in Facilitating Sp1 Degradation through the Up-Regulation of -Transducin Repeat-Containing Protein
- (2009) S. Wei et al. MOLECULAR PHARMACOLOGY
- Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study
- (2008) T. J. Murtola et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
- (2008) Walter H. Gotlieb et al. GYNECOLOGIC ONCOLOGY
- Sumoylation of Specificity Protein 1 Augments Its Degradation by Changing the Localization and Increasing the Specificity Protein 1 Proteolytic Process
- (2008) Yi-Ting Wang et al. JOURNAL OF MOLECULAR BIOLOGY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic β-cells through restoration of mitochondrial electron transfer
- (2007) S A Hinke et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now